| Diana Olshansky, | |
|
9 Lacrue Ave, Suite 210, Glen Mills, PA 19342-1062 | |
| (800) 578-7906 | |
| (800) 878-5497 |
| Full Name | Diana Olshansky |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 9 Lacrue Ave, Glen Mills, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285961367 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | SL009767 (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Diana Olshansky, Po Box 7, Concordville, PA 19331-0007 Ph: (800) 578-7906 | Diana Olshansky, 9 Lacrue Ave, Suite 210, Glen Mills, PA 19342-1062 Ph: (800) 578-7906 |
News Archive
One in three young athletes who undergo ACL surgery experiences re-injury, according to research presented today at the American Orthopaedic Society for Sports Medicine's Specialty Day. The study examined the long term success of surgery for patients aged 18 years and younger.
Fear protects people from danger. A team from the Technical University of Munich and Helmholtz Zentrum München has discovered that this applies even to pathological anxiety disorders. Patients who generally suffer from severe anxiety are likely to heed the symptoms of a heart attack earlier and seek medical treatment sooner, thus improving their chance of survival.
When a physician discovers cancer in a patient, the first thing the doctor wants to know is whether that cancer has spread, or "metastasized."
In various studies across different countries the reported one year mortality risks after hip fracture can vary anywhere from 5 to 50 %. In India, however, there has been little research on the risk of mortality and functional impairment following hip fracture.
PCI Biotech Holding ASA, the Norwegian drug delivery company focusing on effective delivery of cancer therapeutics, today announced that the first patient has received treatment in the Phase I/II trial with the lead candidate Amphinex(R), which uses a new approach called photochemical internalisation.
› Verified 6 days ago
Haley L Kypers, SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 300 Franklin Dr, Glen Mills, PA 19342 Phone: 610-936-6514 | |
Carly Gross, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 9 Lacrue Ave, Glen Mills, PA 19342 Phone: 800-578-7906 Fax: 800-878-5497 | |
Stephanie D. Phelps, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 9 Lacrue Ave, Glen Mills, PA 19342 Phone: 800-578-7906 Fax: 800-878-5497 | |
Tanya Srouji, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 9 Lacrue Ave, Glen Mills, PA 19342 Phone: 800-578-7906 Fax: 800-878-5497 | |
Amy Hartford-jacobs, MA CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 200 Maris Grove Way, Glen Mills, PA 19342 Phone: 610-387-4622 | |
Lynn Gabos, CCC/SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 8 Thomas Speakman Dr, Glen Mills, PA 19342 Phone: 610-613-1498 | |
Goldy Levy, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 9 Lacrue Ave, Glen Mills, PA 19342 Phone: 800-578-7906 Fax: 800-878-5497 |